The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination

AIDS

Volumn 29, Issue 2, 2015, Pages 155-165

  Jones, Christine E ^a,b,c   Hesseling, Anneke C ^d   Tena Coki, Nontobeko G ^a,b   Scriba, Thomas J ^e   Chegou, Novel N ^f   Kidd, Martin ^f   Wilkinson, Robert J ^a,b,g   Kampmann, Beate ^a,b,h  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF STELLENBOSCH   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^h MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Bacille Calmette Gu rin; HIV infection; HIV exposed; Immunogenicity; Mycobacterium tuberculosis infection; Uninfected infants; Vaccination

Indexed keywords

BCG VACCINE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; NEVIRAPINE; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE; TUMOR NECROSIS FACTOR;

ARTICLE; BIRTH; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; DELIVERY; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; INFANCY; INFANT; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MOTHER; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SENSITIZATION; SUPERNATANT; ADULT; CELLULAR IMMUNITY; COHORT ANALYSIS; IMMUNOLOGY; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VACCINATION; VIROLOGY; YOUNG ADULT;

ADULT; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; INFANT; INTERFERON-GAMMA; MATERNAL EXPOSURE; MYCOBACTERIUM TUBERCULOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; YOUNG ADULT;

EID: 84920155060     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000536     Document Type: Article

References (49)

1. Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-526.
2. Shapiro RL, Lockman S, Kim S, Smeaton L, Rahkola JT, Thior I, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 2007; 196:562-569.
3. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Lutalo T, Nalugoda F, et al . Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2006; 41 :504-508.
4. Nakiyingi JS, Bracher M, Whitworth JA, Ruberantwari A, Busingye J, Mbulaiteye SM, et al. Child survival in relation to mother's HIV infection and survival: evidence from a Ugandan cohort study. AIDS 2003; 17:1827-1834.
5. Newell M-L, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236-1243.
6. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
7. McNally LM, Jeena PM, Gajee K, Thula SA, Sturm AW, Cassol S, et al . Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007; 369:1440-1451.
8. Otieno RO, Ouma C, Ong'echa JM, Keller CC, Were T, Waindi EN, et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 2006; 20:275-280.
9. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010; 126:e631-e638.
10. Torre P, Zeldow B, Hoffman HJ, Buchanan A, Siberry GK, Rice M, et al. Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents. Pediatr Infect Dis J 2012; 31:835-841.
11. Madhi SA, Nachman S, Violari A, Kim S, Cotton MF, Bobat R, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011; 365:21-31.
12. Schramm DB, Kuhn L, Gray GE, Tiemessen CT. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr 2006; 42:545-553.
13. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
14. Miles DJC, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology 2010;129 :446-454.
15. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sørensen TU, Dreves AM, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98:398-404.
16. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997; 4:358-361.
17. Embree J, Bwayo J, Nagelkerke N, Njenga S, Nyange P, Ndinya- Achola J, et al. Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. Pediatr Infect Dis J 2001; 20:397-403.
18. Borges-Almeida E, Milanez HM, Vilela MMS, Cunha FG, Abramczuk BM, Reis-Alves SC, et al. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed noninfected newborns. BMC Infect Dis 2011; 11: 38.
19. Ono E, Nunes dos Santos AM, de Menezes Succi RC, Machado DM, de Angelis DSA, Salomão R, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res 2008;41:700-708.
20. Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol 2008; 126:243-250.
21. Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NL, Liewehr DJ, et al. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis 2000; 181:1590-1597.
22. Kuhn L, Coutsoudis A, Moodley D, Mngqundaniso N, Trabattoni D, Shearer GM, et al. Interferon-gamma and interleukin-10 production among HIV-1-infected and uninfected infants of HIV-1-infected mothers. Pediatr Res 2001; 50:412-416.
23. Adegnika AA, Köhler C, Agnandji ST, Chai SK, Labuda L, Breitling LP, et al. Pregnancy-associated malaria affects tolllike receptor ligand-induced cytokine responses in cord blood. J Infect Dis 2008; 198:928-936.
24. Malhotra I, Mungai P, Wamachi A, Kioko J, Ouma JH, Kazura JW, et al. Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162:6843-6848.
25. Malhotra I, Ouma J, Wamachi A, Kioko J, Mungai P, Omollo A, et al. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest 1997; 99:1759-1766.
26. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to post-natal infections. Lancet Infect Dis 2012; 12:330-340.
27. Van Rie A, Madhi SA, Heera JR, Meddows-Taylor S, Wendelboe AM, Anthony F, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006;13:246-252.
28. Kampmann B, Tena GN, Mzazi S, Eley B, Young DB, Levin M. Novel human in vitro system for evaluating antimycobacterial vaccines. Infect Immun 2004; 72:6401-6407.
29. van den Biggelaar AHJ, Prescott SL, Roponen M, Nadal-Sims MA, Devitt CJ, Phuanukoonnon S, et al. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. J Allergy Clin Immunol 2009; 124:544.e2-550.e2.
30. City of Cape Town Department of Health. City health HIV, AIDS, STI and TB plan 2012/2013. Available from: http://www.capetown.gov.za/en/IDP/Documents/Statutory%20compliance%20plans%20201213/AnnexureI-HIV-Aids-STI-TB-Plan-2012-2013.pdf [accessed 28 November 2014].
31. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305:576-584.
32. World Health Organization. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec 2007; 82:193-196.
33. Soares A, Govender L, Hughes J, Mavakla W, De Kock M, Barnard C, et al. Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods 2010; 362:43-50.
34. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182:311-322.
35. Kemp K, Bruunsgaard H. Identification of IFN-gamma-producing CD4+ T cells following PMA stimulation. J Interferon Cytokine Res 2001; 21:503-506.
36. Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of postcytometric complex multivariate datasets. Cytometry A 2011; 79:167-174.
37. Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S, et al. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008; 12:225-227.
38. Schramm DB, Meddows-Taylor S, Gray GE, Kuhn L, Tiemessen CT. Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses. Clin Vaccine Immunol 2007; 14:348-354.
39. Economides A, Schmid I, Anisman-Posner DJ, Plaeger S, Bryson YJ, Uittenbogaart CH. Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1998; 5:230-234.
40. Resino S, Seoane E, Gutiérrez MDG, León JA, Muñoz-Fernández MA. CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42:269-276.
41. Rahman MJ, Dégano IR, Singh M, Fernández C. Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model. PLoS One 2010; 5:e9699.
42. Weir RE, Black GF, Nazareth B, Floyd S, Stenson S, Stanley C, et al . The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi. Clin Exp Immunol 2006; 146 :390-399.
43. Puissant-Lubrano B, Combadiere B, Duffy D, Wincker N, Frachette M-J, Ait-Mohand H, et al. Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients. Vaccine 2009; 27:3576-3583.
44. Elrefaei M, McElroy MD, Preas CP, Hoh R, Deeks S, Martin J, et al. Central memory CD4R T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol 2004; 173:2184-2189.
45. Combadiere B, Boissonnas A, Carcelain G, Lefranc E, Samri A, Bricaire F, et al. Distinct time effects of vaccination on longterm proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med 2004; 199:1585-1593.
46. Mansoor N, Scriba TJ, De Kock M, Tameris M, Abel B, Keyser A, et al. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis 2009; 199:982-990.
47. Hanekom WA, Dockrell HM, Ottenhoff THM, Doherty TM, Fletcher H, Mcshane H, et al. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med 2008; 5:e145.
48. Elliott AM, Mawa PA, Webb EL, Nampijja M, Lyadda N, Bukusuba J, et al. Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine 2010; 29:247-255.
49. Mazzola TN, da Silva MTN, Abramczuk BM, Moreno YMF, Lima SCBS, Zorzeto TQ, et al. Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants. AIDS 2011; 25:2079-2087.